Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I study (Q33504586)
scientific article
Language:
Current Data About Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I study
(P31) (Q13442814)
(P248)
(P698) 9848577
(P813) Thursday, July 27, 2017

(P304) 141-146
(P248)
(P698) 9848577
(P813) Thursday, July 27, 2017

(P433) 2
(P248)
(P698) 9848577
(P813) Thursday, July 27, 2017

(P478) 16
(P248)
(P698) 9848577
(P813) Thursday, July 27, 2017

(P577) Thursday, January 1, 1998
(P248)
(P698) 9848577
(P813) Thursday, July 27, 2017

(P1433) (Q2312231)
(P248)
(P698) 9848577
(P813) Thursday, July 27, 2017

(P1476) "Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I study" (language: en)
(P248)
(P698) 9848577
(P813) Thursday, July 27, 2017

(P2093) D Lüftner
(P1545) 1
(P248)
(P698) 9848577
(P813) Thursday, July 27, 2017

B Flath
(P1545) 2
(P248)
(P698) 9848577
(P813) Thursday, July 27, 2017

C Akrivakis
(P1545) 3
(P248)
(P698) 9848577
(P813) Thursday, July 27, 2017

H G Mergenthaler
(P1545) 4
(P248)
(P698) 9848577
(P813) Thursday, July 27, 2017

U Ohnmacht
(P1545) 5
(P248)
(P698) 9848577
(P813) Thursday, July 27, 2017

M Arning
(P1545) 6
(P248)
(P698) 9848577
(P813) Thursday, July 27, 2017

K Possinger
(P1545) 7
(P248)
(P698) 9848577
(P813) Thursday, July 27, 2017

(P2860) (Q36286955)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/9848577
(P813) Saturday, December 12, 2020
(P887)

(Q59828351)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/9848577
(P813) Saturday, December 12, 2020
(P887)

(Q40435002)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/9848577
(P813) Saturday, December 12, 2020
(P887)

(Q41388354)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/9848577
(P813) Saturday, December 12, 2020
(P887)

other details
description scientific article

External Links
(P356) 10.1023/A:1006121608414
(P698) 9848577
(P6179) 1041656360